Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Jessica R. Stuart"'
Autor:
Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James C. Bennett, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Molly R. Lennard-Jones, Rasmus W. Licht, Lindsey Marwood, Sunil Mistry, Tomáš Páleníček, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie J. Simmons, Jair C. Soares, Metten Somers, Susan C. Stansfield, Jessica R. Stuart, Hannah H. Tadley, Nisha K. Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I. Winzer, Allan H. Young, Matthew B. Young, Sid Zisook, Ekaterina Malievskaia
Publikováno v:
Journal of Affective Disorders, 327, 120-127. ELSEVIER SCIENCE BV
Goodwin, G M, Aaronson, S T, Alvarez, O, Atli, M, Bennett, J C, Croal, M, DeBattista, C, Dunlop, B W, Feifel, D, Hellerstein, D J, Husain, M I, Kelly, J R, Lennard-Jones, M R, Licht, R W, Marwood, L, Mistry, S, Páleníček, T, Redjep, O, Repantis, D, Schoevers, R A, Septimus, B, Simmons, H J, Soares, J C, Somers, M, Stansfield, S C, Stuart, J R, Tadley, H H, Thiara, N K, Tsai, J, Wahba, M, Williams, S, Winzer, R I, Young, A H, Young, M B, Zisook, S & Malievskaia, E 2023, ' Single-dose psilocybin for a treatment-resistant episode of major depression : Impact on patient-reported depression severity, anxiety, function, and quality of life ', Journal of Affective Disorders, vol. 327, pp. 120-127 . https://doi.org/10.1016/j.jad.2023.01.108
Goodwin, G M, Aaronson, S T, Alvarez, O, Atli, M, Bennett, J C, Croal, M, DeBattista, C, Dunlop, B W, Feifel, D, Hellerstein, D J, Husain, M I, Kelly, J R, Lennard-Jones, M R, Licht, R W, Marwood, L, Mistry, S, Páleníček, T, Redjep, O, Repantis, D, Schoevers, R A, Septimus, B, Simmons, H J, Soares, J C, Somers, M, Stansfield, S C, Stuart, J R, Tadley, H H, Thiara, N K, Tsai, J, Wahba, M, Williams, S, Winzer, R I, Young, A H, Young, M B, Zisook, S & Malievskaia, E 2023, ' Single-dose psilocybin for a treatment-resistant episode of major depression : Impact on patient-reported depression severity, anxiety, function, and quality of life ', Journal of Affective Disorders, vol. 327, pp. 120-127 . https://doi.org/10.1016/j.jad.2023.01.108
BACKGROUND: COMP360 is a proprietary, synthetic formulation of psilocybin being developed for treatment-resistant depression (TRD), a burdensome, life-threatening illness with high global impact. Here, we expand upon the previous report of primary ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::013e8a6c885ca2e1175149333269793f
https://research.rug.nl/en/publications/7815d748-d592-41b2-af6f-143333fd1a5d
https://research.rug.nl/en/publications/7815d748-d592-41b2-af6f-143333fd1a5d
